Measuring Nerve Activity in Small Human Intestinal Biopsies in IBS (Irritable Bowel Syndrome)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01912313|
Recruitment Status : Recruiting
First Posted : July 31, 2013
Last Update Posted : February 9, 2017
Rectal biopsies from IBS patients or healthy subjects will be taken.
Biopsies will be used for:
- the isolation of submucosal plexus to perform: 1.1 live nerve recordings and Calcium imaging; 1.2 immunohistochemistry; 1.3 mRNA (Messenger ribonucleic acids) isolation and real time PCR (Polymerase chain reaction);
- culturing biopsies
On the basis of these observations, the general aim of the study is to move a significant step forward in the current knowledge on human ENS (enteric nervous system) in IBS by establishing a live imaging method to record enteric nerves activity in small intestinal biopsies from humans. This development is unique in its kind as not other research groups have reported successful live recordings with calcium imaging in this preparation.
In particular, the investigators aim:
- to develop and validate the technique to measure activity in human enteric nerves in the submucous plexus isolated from rectal biopsies from healthy subjects and IBS patients;
- to characterize this nerve activity in healthy subjects and IBS patients using both calcium imaging to evaluate the effect of different neuromodulators, immunohistochemistry and rtPCR to determine receptor expression levels and identify neurons and glial cells in the submucous ganglia;
- to investigate whether the biopsies of IBS patients secrete more modulators/cytokines compared to healthy subjects and their potential to activate neurons.
- to evaluate the influence of different food constituents (cow‟s milk, wheat, yeast, gluten and soy) on the local reaction of the rectal mucosa and evaluate mast cell activation/degranulation in biopsies of IBS patients compared to healthy subjects.
- To evaluate the amount of inflammatory mediators/metabolites in urine samples of IBS patients and healthy volunteers by the use of metabolic profiling
|Condition or disease||Intervention/treatment||Phase|
|IBS Healthy||Procedure: Rectal biopsies from IBS patients or healthy subjects will be taken during proctoscopy||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||99999999 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Basic Science|
|Official Title:||Measuring Nerve Activity in Small Human Intestinal Biopsies in IBS (Irritable Bowel Syndrome)|
|Study Start Date :||August 2013|
|Estimated Primary Completion Date :||August 2019|
|Estimated Study Completion Date :||August 2019|
|Experimental: Rectal biopsy||Procedure: Rectal biopsies from IBS patients or healthy subjects will be taken during proctoscopy|
- nerve activity in healthy subjects and IBS patients [ Time Frame: Starting from the moment biopsies are collected untill nerve activity in samples is lost (approximately 5 hours) ]Measuring nerve activity in healthy subjects and IBS patients using both calcium imaging to evaluate the effect of different neuromodulators, immunohistochemistry and rtPCR to determine receptor expression levels and identify neurons and glial cells in the submucous ganglia.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01912313
|Contact: Lien Beullens, MScfirstname.lastname@example.org|
|Contact: Dafne Balemans, MScemail@example.com|
|University Hospitals Leuven||Recruiting|
|Leuven, Vlaams-Brabant, Belgium, 3000|
|Contact: Lien Beullens, MSc 0032-16-341943 firstname.lastname@example.org|
|Contact: Dafne Balemans, MSc 0032-16-330158 email@example.com|
|Principal Investigator:||Guy Boeckxstaens, MD||Catholic University Leuven and Universitary Hospitals Leuven|